openPR Logo
Press release

Peptide CDMO (Pharmaceutical) Market in 2025 Detailed Study Analysis

Peptide CDMO (Pharmaceutical) Market in 2025 Detailed Study

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Peptide CDMO (Pharmaceutical) Market Trends, Industry Competition Analysis, Company Profiles, Revenue Estimates and Forecast To 2034."

According to the latest market research report, the global Peptide CDMO (Pharmaceutical) Market Size is valued at 2.5 Bn in 2024 and is predicted to reach 6.6 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1202

Peptides, which are short chains of amino acids, play a critical role in addressing unmet medical needs. Peptide-based therapeutics have become integral in the treatment of conditions such as cancer, diabetes, osteoporosis, chronic pain, multiple sclerosis, and HIV. Owing to their distinct therapeutic properties and considerable potential in the contract active pharmaceutical ingredient (API) manufacturing sector, peptide contract development and manufacturing organizations (CDMOs) are emerging as a key segment of the market.

Market growth in the peptide CDMO sector is expected to be driven by factors such as advancements in healthcare infrastructure, expanding therapeutic applications of peptides, rising healthcare expenditures, and the development of innovative peptide design technologies. Additionally, increased utilization of peptides in drug development, growing R&D investments in peptide-based therapies, and the high prevalence of chronic diseases are contributing to market expansion.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1202

Regionally, North America, followed by Europe, is projected to lead the peptide CDMO (pharmaceutical) market during the forecast period (2022-2030), owing to the well-developing CDMOs, availability of peptide synthesis technologies, and the surging demand for peptides and drugs to treat chronic conditions.
Key market players operating in the peptide CDMO (pharmaceutical) market include AmbioPharm, Auspep, Bachem, BCN Peptide, CPC Scientific, CBL- Chemical and Biopharmaceutical Laboratories, ScinoPharm, Olon, Belyntic, Ferring Pharma, Numaferm, Hybio Pharmaceutical, Provepharm life solutions, Enzene Biosciences, Ardena Holding, Stelis Biopharma, Piramal Pharma, Space Peptides PharmaceuticalCreative Peptides, CSBio, Corden Pharma, PolyPeptide, Hybio Pharmaceutical, Peptide Institute, Pepscan, Almac, Chinese Peptide, CreoSalus Inc, Vivitide, Senn Chemicals, Wuxi AppTec, among others.

Key developments in the market:
• In January 2022, CordenPharma collaborated with PeptiSystems, a Swedish-based developer of peptide and oligonucleotide therapeutic process development and manufacturing instruments, to reduce the footprint impact and improve the Process Mass Intensity (PMI) of peptide manufacturing processes.
• In December 2021, Pepscan extended its column purification technology with a mid-sized column packer. This technology significantly reduces purification time and provides optimal flexibility when synthesizing peptides.
• In September 2021, CEM Corporation and AmbioPharm, Inc. partnered to produce GMP peptides for the global market. The partnership will involve an exclusive1 use of CEM's large-scale microwave peptide synthesis technology to produce GMP peptides up to multi-kilogram quantities using proprietary scalable reactors. Also, it will enable rapid and efficient production of peptide new chemical entities (NCE's) using the latest technologies available.
• In July 2021, CordenPharma expanded its peptide manufacturing capacity in CordenPharma Colorado, their GMP API facility in Boulder, CO (US). CordenPharma Colorado is the largest worldwide peptide API producer leading the global peptide market.

Get Specific Chapter/Information From The Report: @ https://www.insightaceanalytic.com/customisation/1202

Market Segments
Global Peptide CDMO (Pharmaceutical) Market, by Scale of Operation, 2025-2034 (Value US$ Mn)
• Preclinical / Clinical
• Commercial
Global Peptide CDMO (Pharmaceutical) Market, by Method Used, 2025-2034 (Value US$ Mn)
• Chemical Synthesis Method
• Non-Chemical Synthesis Method
Global Peptide CDMO (Pharmaceutical) Market, by By Applications, 2025-2034 (Value US$ Mn)
• Peptide Supplements
• Peptide Vaccines
• Peptides as Radio-Theranostic Agents
• Cell Penetrating Peptides (CPPs)
• Affinity Ligands
• Protein Mimics
Global Peptide CDMO (Pharmaceutical) Market, by Synthesis Types, 2025-2034 (Value US$ Mn)
• LPPS
• SPPS
• Mixed Phase
Global Peptide CDMO (Pharmaceutical) Market, by Region, 2025-2034 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• The U.S.
• Canada
Europe Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of the Middle East & Africa

Get More Information :
https://www.insightaceanalytic.com/report/global-peptide-cdmo-pharmaceutical-market-/1202

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide CDMO (Pharmaceutical) Market in 2025 Detailed Study Analysis here

News-ID: 4302387 • Views: …

More Releases from Insightace Analytic Pvt Ltd.

Cosmetic Pigments Market Size Evaluation and Growth Forecast 2026 to 2035
Cosmetic Pigments Market Size Evaluation and Growth Forecast 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cosmetic Pigments Market Size, Share & Trends Analysis Report By Composition (Organic Pigments, Inorganic Pigments), By Type (Special-Effect Pigments, Surface-Treated Pigments, Nano Pigments, Natural Colorants), By Application (Facial Makeup, Eye Makeup, Lip Products, Nail Products, Hair Color Products, Special-Purpose Products, Other Applications),-Market Outlook And Industry Analysis 2035" Cosmetic Pigments Market Size is valued at USD 0.73…
Post-Procedure Skincare Market Emerging Trends and Long-Term Forecast 2026 to 2035
Post-Procedure Skincare Market Emerging Trends and Long-Term Forecast 2026 to 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Post-Procedure Skincare Market Size, Share & Trends Analysis Report By Product Function (Barrier Repair & Recovery Moisturizers, Soothing & Anti-Redness Products, Regenerative & Collagen-Support Products, Post-Procedure Photoprotection, Gentle Cleansers & Procedure Prep, Scar & Pigmentation Management), By Format (Cream & Balm, Serum & Ampoule, Gel, Lotion & Emulsion, Foam & Liquid Wash, Mask & Patch),…
Creatine Ingredients Market Dynamics and Revenue Forecast 2026 to 2035
Creatine Ingredients Market Dynamics and Revenue Forecast 2026 to 2035
InsightAce Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Creatine Ingredients Market Size, Share & Trends Analysis Report by Product Type (Creatine Monohydrate, Standard Powder, Micronized Powder, Specialty-Processed, Creatine Hydrochloride, Other Creatine Forms), by Application (Sports Nutrition Supplements, Health & Wellness Supplements, Functional Foods & Beverages, Pharmaceutical, Medical Nutrition & Other Applications), by Distribution Channel (Direct Sales, Distributors & Traders) and Market Outlook and…
Functional Pet Nutrition Ingredients Market Strategic Growth Drivers and Outlook 2026 to 2035
Functional Pet Nutrition Ingredients Market Strategic Growth Drivers and Outlook …
InsightAce Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Functional Pet Nutrition Ingredients Market Size, Share & Trends Analysis Report by Ingredient Category (Biotics, Probiotics, Prebiotics & Functional Fibers, Postbiotics & Yeast Fermentates, Omega-3 Fatty Acids, Refined Fish Oil, Krill Meal & Krill Oil, Algal Oil, Joint & Mobility Ingredients, Glucosamine & Chondroitin, Collagen Peptides & Undenatured Type II Collagen, Green-Lipped Mussel, Eggshell Membrane…

All 5 Releases


More Releases for Peptide

Custom Peptide Synthesis and CDMO Services Accelerate Peptide Drug Development
Hangzhou, Zhejiang, China - November7, 2026 - Peptide Therapeutic [https://www.thinhealpeptide.com/peptide-therapeutic/]s have grown steadily as a promising class of drug candidates, valued for their high target selectivity, relatively low off-target toxicity and flexible structural modification. Yet peptide drug development remains technically demanding. Many biotech and research teams lack in-house capacity for complex synthesis, analytical validation and regulated manufacturing. This is where custom peptide synthesis and professional CDMO support become decisive to…
Peptide Companies Reviewed Launches Independent Resource to Help Readers Compare …
The educational platform introduces a structured review methodology focused on transparency, documentation, testing standards, and fulfillment practices to help readers evaluate research peptide suppliers with greater confidence. Los Angeles, CA - August 17, 2026 - Peptide Companies Reviewed has launched an independent online resource designed to help readers compare research peptide suppliers using consistent editorial standards and publicly available information. The platform provides educational reviews and research guides that focus on…
08-11-2026 | Health & Medicine
Getnews
Peptide Pod Launches a New Platform Bringing Peptide Podcasts and Research Toget …
The world's first dedicated peptide podcast platform brings trusted education, research, and leading voices together in one place. United States - August 10, 2026 - As interest in peptides continues to rise, finding trustworthy educational content has become increasingly difficult. New podcasts, research papers, and online discussions appear almost daily, leaving many people searching across multiple websites to stay informed. Peptide Pod [https://peptidepod.com/] is changing that by bringing peptide podcasts, research,…
Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity. United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity. The platform gives researchers access to more than 30 research compounds, each independently tested by third-party…
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity. This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…